Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3)

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

Prof Sir Martin Landray, FMedSci
Professor of Medicine & Epidemiology
University of Oxford
Chief Executive, Protas

Khair ElZarrad, PhD, MPH
Director, Office of Medical Policy
Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration (FDA)

Adrian F. Hernandez, MD, MHS
Vice Dean and Executive Director
Duke Clinical Research Institute
Duke University School of Medicine

Learn More